Chiemi Matsumi

Title: Chiemi Matsumi: Innovator in Anti-Cancer Antibody Development

Introduction

Chiemi Matsumi is a prominent inventor based in Komagane, Japan. She has made significant contributions to the field of cancer research through her innovative work on antibodies with anti-cancer activity. Her dedication to advancing medical science is evident in her research and patent achievements.

Latest Patents

Chiemi Matsumi holds a patent for an antibody that exhibits anti-cancer activity. By utilizing an SST-REX method, she selected a cDNA encoding a protein expressed on a cell surface or secreted from a cancer cell line from a cDNA library. Monoclonal antibodies against the protein encoding the selected cDNA were prepared. The in vitro and in vivo anti-cancer activities and binding to various cancer cell lines were examined. As a result, a monoclonal antibody that binds to a PODXL2 protein, which demonstrated excellent anti-cancer activities, was discovered. Furthermore, a region including an epitope of the antibody was successfully identified, and the amino acid sequences of variable regions of a light chain and a heavy chain were successfully determined.

Career Highlights

Chiemi Matsumi is currently associated with Actgen Inc., where she continues her research and development efforts. Her work has positioned her as a key figure in the field of antibody research, particularly in the context of cancer treatment.

Collaborations

Chiemi has collaborated with notable colleagues, including Masunori Kajikawa and Masahito Sugiura, who have contributed to her research endeavors.

Conclusion

Chiemi Matsumi's innovative work in developing anti-cancer antibodies showcases her commitment to advancing medical science. Her contributions are paving the way for new therapeutic approaches in cancer treatment.